世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000038899

暴食性障害治療の世界市場(2024-2028)

TechNavio

Global binge-eating disorder treatment market 2024-2028

発刊日 2024/05/21

言語英語

体裁PDF/164ページ

ライセンス/価格164ページ

0000038899

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

暴食性障害治療市場は2023年から2028年に5億6,870万米ドル、予測期間中のCAGRは6.78%で成長すると予測されます。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場は、暴食性障害の有病率の増加、肥満人口の増加、政府のイニシアチブの高まりによって牽引されています。

調査範囲

  • 市場セグメント
    ➣ 流通チャネル別
      ◇ オフライン
      ◇ オンライン
    ➣ タイプ別
      ◇ 抗うつ薬
      ◇ 抗けいれん薬
      ◇ 覚醒剤など
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ 世界のその他の地域

この調査では、新薬の市場開発と承認が今後数年間の暴食性障害治療市場成長を牽引する主要因の1つであるとしています。また、部分入院プログラム(PHP)への嗜好の高まりやバーチャル遠隔医療の出現は、市場の大きな需要につながります。

暴食性障害治療市場に関するレポートは、次の分野をカバーしています。

  • 暴食性障害治療市場の規模
  • 暴食性障害治療市場の予測
  • 暴食性障害治療市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。

  • 調査企業
    ➣ Alvogen Iceland ehf
    ➣ Bausch Health Companies Inc.
    ➣ Chronos Therapeutics Ltd
    ➣ Currax Pharmaceuticals LLC
    ➣ Eli Lilly and Co.
    ➣ Johnson and Johnson Services Inc.
    ➣ Lupin Ltd.
    ➣ Omeros Corp.
    ➣ Pyramid Healthcare Inc.
    ➣ Rosewood Centers for Eating disorders
    ➣ 住友ファーマ(Sumitomo Pharma Co. Ltd.)
    ➣ 武田製薬工業(Takeda Pharmaceutical Co. Ltd.)
    ➣ Timberline Knolls Residential Treatment Center
    ➣ Tonix Pharmaceuticals Holding Corp.
    ➣ Tryp Therapeutics Inc.
    ➣ Viatris Inc.
    ➣ VIVUS LLC
    ➣ Walden Behavioral Care

また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market by Geography
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global Binge-Eating Disorder Treatment Market 2018 - 2022
Historic Market Size - Data Table on Global Binge-Eating Disorder Treatment Market 2018 - 2022 ($ million)
4.2 Distribution Channel segment analysis 2018 - 2022
Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.3 Type segment analysis 2018 - 2022
Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Distribution Channel
6.1 Market segments
Chart on Distribution Channel - Market share 2023-2028 (%)
Data Table on Distribution Channel - Market share 2023-2028 (%)
6.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
6.3 Offline - Market size and forecast 2023-2028
Chart on Offline - Market size and forecast 2023-2028 ($ million)
Data Table on Offline - Market size and forecast 2023-2028 ($ million)
Chart on Offline - Year-over-year growth 2023-2028 (%)
Data Table on Offline - Year-over-year growth 2023-2028 (%)
6.4 Online - Market size and forecast 2023-2028
Chart on Online - Market size and forecast 2023-2028 ($ million)
Data Table on Online - Market size and forecast 2023-2028 ($ million)
Chart on Online - Year-over-year growth 2023-2028 (%)
Data Table on Online - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ million)
Data Table on Market opportunity by Distribution Channel ($ million)

7 Market Segmentation by Type
7.1 Market segments
Chart on Type - Market share 2023-2028 (%)
Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
7.3 Antidepressants - Market size and forecast 2023-2028
Chart on Antidepressants - Market size and forecast 2023-2028 ($ million)
Data Table on Antidepressants - Market size and forecast 2023-2028 ($ million)
Chart on Antidepressants - Year-over-year growth 2023-2028 (%)
Data Table on Antidepressants - Year-over-year growth 2023-2028 (%)
7.4 Anticonvulsants - Market size and forecast 2023-2028
Chart on Anticonvulsants - Market size and forecast 2023-2028 ($ million)
Data Table on Anticonvulsants - Market size and forecast 2023-2028 ($ million)
Chart on Anticonvulsants - Year-over-year growth 2023-2028 (%)
Data Table on Anticonvulsants - Year-over-year growth 2023-2028 (%)
7.5 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape2023-2028 (%)
Data Table on Market share By Geographical Landscape2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 India - Market size and forecast 2023-2028
Chart on India - Market size and forecast 2023-2028 ($ million)
Data Table on India - Market size and forecast 2023-2028 ($ million)
Chart on India - Year-over-year growth 2023-2028 (%)
Data Table on India - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Market opportunity By Geographical Landscape($ million)
Data Tables on Market opportunity By Geographical Landscape($ million)

10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business

12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Alvogen Iceland ehf
Alvogen Iceland ehf - Overview
Alvogen Iceland ehf - Product / Service
Alvogen Iceland ehf - Key offerings
12.4 Bausch Health Companies Inc.
Bausch Health Companies Inc. - Overview
Bausch Health Companies Inc. - Business segments
Bausch Health Companies Inc. - Key news
Bausch Health Companies Inc. - Key offerings
Bausch Health Companies Inc. - Segment focus
12.5 Chronos Therapeutics Ltd.
Chronos Therapeutics Ltd. - Overview
Chronos Therapeutics Ltd. - Product / Service
Chronos Therapeutics Ltd. - Key offerings
12.6 Currax Pharmaceuticals LLC
Currax Pharmaceuticals LLC - Overview
Currax Pharmaceuticals LLC - Product / Service
Currax Pharmaceuticals LLC - Key offerings
12.7 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key news
Eli Lilly and Co. - Key offerings
12.8 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
12.9 Lupin Ltd.
Lupin Ltd. - Overview
Lupin Ltd. - Product / Service
Lupin Ltd. - Key news
Lupin Ltd. - Key offerings
12.10 Omeros Corp.
Omeros Corp. - Overview
Omeros Corp. - Product / Service
Omeros Corp. - Key offerings
12.11 Pyramid Healthcare Inc.
Pyramid Healthcare Inc. - Overview
Pyramid Healthcare Inc. - Product / Service
Pyramid Healthcare Inc. - Key offerings
12.12 Sumitomo Pharma Co. Ltd.
Sumitomo Pharma Co. Ltd. - Overview
Sumitomo Pharma Co. Ltd. - Business segments
Sumitomo Pharma Co. Ltd. - Key news
Sumitomo Pharma Co. Ltd. - Key offerings
Sumitomo Pharma Co. Ltd. - Segment focus
12.13 Takeda Pharmaceutical Co. Ltd.
Takeda Pharmaceutical Co. Ltd. - Overview
Takeda Pharmaceutical Co. Ltd. - Product / Service
Takeda Pharmaceutical Co. Ltd. - Key news
Takeda Pharmaceutical Co. Ltd. - Key offerings
12.14 Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp. - Overview
Tonix Pharmaceuticals Holding Corp. - Product / Service
Tonix Pharmaceuticals Holding Corp. - Key offerings
12.15 Tryp Therapeutics Inc.
Tryp Therapeutics Inc. - Overview
Tryp Therapeutics Inc. - Product / Service
Tryp Therapeutics Inc. - Key offerings
12.16 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus
12.17 VIVUS LLC
VIVUS LLC - Overview
VIVUS LLC - Product / Service
VIVUS LLC - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Binge-Eating Disorder Treatment Market 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits33: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Distribution Channel
Exhibits35: Data Table on Comparison by Distribution Channel
Exhibits36: Chart on Offline - Market size and forecast 2023-2028 ($ million)
Exhibits37: Data Table on Offline - Market size and forecast 2023-2028 ($ million)
Exhibits38: Chart on Offline - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Offline - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Online - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on Online - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on Online - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Online - Year-over-year growth 2023-2028 (%)
Exhibits44: Market opportunity by Distribution Channel ($ million)
Exhibits45: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits46: Chart on Type - Market share 2023-2028 (%)
Exhibits47: Data Table on Type - Market share 2023-2028 (%)
Exhibits48: Chart on Comparison by Type
Exhibits49: Data Table on Comparison by Type
Exhibits50: Chart on Antidepressants - Market size and forecast 2023-2028 ($ million)
Exhibits51: Data Table on Antidepressants - Market size and forecast 2023-2028 ($ million)
Exhibits52: Chart on Antidepressants - Year-over-year growth 2023-2028 (%)
Exhibits53: Data Table on Antidepressants - Year-over-year growth 2023-2028 (%)
Exhibits54: Chart on Anticonvulsants - Market size and forecast 2023-2028 ($ million)
Exhibits55: Data Table on Anticonvulsants - Market size and forecast 2023-2028 ($ million)
Exhibits56: Chart on Anticonvulsants - Year-over-year growth 2023-2028 (%)
Exhibits57: Data Table on Anticonvulsants - Year-over-year growth 2023-2028 (%)
Exhibits58: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits59: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits60: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits61: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits62: Market opportunity by Type ($ million)
Exhibits63: Data Table on Market opportunity by Type ($ million)
Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits65: Chart on Market share By Geographical Landscape2023-2028 (%)
Exhibits66: Data Table on Market share By Geographical Landscape2023-2028 (%)
Exhibits67: Chart on Geographic comparison
Exhibits68: Data Table on Geographic comparison
Exhibits69: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits101: Chart on India - Market size and forecast 2023-2028 ($ million)
Exhibits102: Data Table on India - Market size and forecast 2023-2028 ($ million)
Exhibits103: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibits104: Data Table on India - Year-over-year growth 2023-2028 (%)
Exhibits105: Market opportunity By Geographical Landscape($ million)
Exhibits106: Data Tables on Market opportunity By Geographical Landscape($ million)
Exhibits107: Impact of drivers and challenges in 2023 and 2028
Exhibits108: Overview on criticality of inputs and factors of differentiation
Exhibits109: Overview on factors of disruption
Exhibits110: Impact of key risks on business
Exhibits111: Companies covered
Exhibits112: Matrix on companies position and classification
Exhibits113: Alvogen Iceland ehf - Overview
Exhibits114: Alvogen Iceland ehf - Product / Service
Exhibits115: Alvogen Iceland ehf - Key offerings
Exhibits116: Bausch Health Companies Inc. - Overview
Exhibits117: Bausch Health Companies Inc. - Business segments
Exhibits118: Bausch Health Companies Inc. - Key news
Exhibits119: Bausch Health Companies Inc. - Key offerings
Exhibits120: Bausch Health Companies Inc. - Segment focus
Exhibits121: Chronos Therapeutics Ltd. - Overview
Exhibits122: Chronos Therapeutics Ltd. - Product / Service
Exhibits123: Chronos Therapeutics Ltd. - Key offerings
Exhibits124: Currax Pharmaceuticals LLC - Overview
Exhibits125: Currax Pharmaceuticals LLC - Product / Service
Exhibits126: Currax Pharmaceuticals LLC - Key offerings
Exhibits127: Eli Lilly and Co. - Overview
Exhibits128: Eli Lilly and Co. - Product / Service
Exhibits129: Eli Lilly and Co. - Key news
Exhibits130: Eli Lilly and Co. - Key offerings
Exhibits131: Johnson and Johnson Services Inc. - Overview
Exhibits132: Johnson and Johnson Services Inc. - Business segments
Exhibits133: Johnson and Johnson Services Inc. - Key news
Exhibits134: Johnson and Johnson Services Inc. - Key offerings
Exhibits135: Johnson and Johnson Services Inc. - Segment focus
Exhibits136: Lupin Ltd. - Overview
Exhibits137: Lupin Ltd. - Product / Service
Exhibits138: Lupin Ltd. - Key news
Exhibits139: Lupin Ltd. - Key offerings
Exhibits140: Omeros Corp. - Overview
Exhibits141: Omeros Corp. - Product / Service
Exhibits142: Omeros Corp. - Key offerings
Exhibits143: Pyramid Healthcare Inc. - Overview
Exhibits144: Pyramid Healthcare Inc. - Product / Service
Exhibits145: Pyramid Healthcare Inc. - Key offerings
Exhibits146: Sumitomo Pharma Co. Ltd. - Overview
Exhibits147: Sumitomo Pharma Co. Ltd. - Business segments
Exhibits148: Sumitomo Pharma Co. Ltd. - Key news
Exhibits149: Sumitomo Pharma Co. Ltd. - Key offerings
Exhibits150: Sumitomo Pharma Co. Ltd. - Segment focus
Exhibits151: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits152: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits153: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits154: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits155: Tonix Pharmaceuticals Holding Corp. - Overview
Exhibits156: Tonix Pharmaceuticals Holding Corp. - Product / Service
Exhibits157: Tonix Pharmaceuticals Holding Corp. - Key offerings
Exhibits158: Tryp Therapeutics Inc. - Overview
Exhibits159: Tryp Therapeutics Inc. - Product / Service
Exhibits160: Tryp Therapeutics Inc. - Key offerings
Exhibits161: Viatris Inc. - Overview
Exhibits162: Viatris Inc. - Business segments
Exhibits163: Viatris Inc. - Key news
Exhibits164: Viatris Inc. - Key offerings
Exhibits165: Viatris Inc. - Segment focus
Exhibits166: VIVUS LLC - Overview
Exhibits167: VIVUS LLC - Product / Service
Exhibits168: VIVUS LLC - Key offerings
Exhibits169: Inclusions checklist
Exhibits170: Exclusions checklist
Exhibits171: Currency conversion rates for US$
Exhibits172: Research methodology
Exhibits173: Information sources
Exhibits174: Data validation
Exhibits175: Validation techniques employed for market sizing
Exhibits176: Data synthesis
Exhibits177: 360 degree market analysis
Exhibits178: List of abbreviations

この商品のレポートナンバー

0000038899

TOP